[DISCLOSURE] Kolon Life Science (102940) said on Aug.2 that its consolidated operating profit in the second quarter rose 352.2 percent on-year, reaching 3.4 billion won (US$3.06 million). Sales rose 6.7 percent to 36.08 billion won while net profit amounted 2.3 billion won up 2061.1 percent.